Press releases

articles from April 2018

Orchard Therapeutics Expands US Presence with New Corporate Office in Boston

Orchard Therapeutics today announced the opening of a new U.S. office in Boston’s Seaport District. The new Boston office builds upon the company’s footprint in London as well as Foster City and Menlo Park, California

Read more

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients

Read more